Integrated Research Limited (IREHF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Integrated Research Limited (IREHF) with AI Score 47/100 (Weak). Integrated Research Limited (IREHF) specializes in systems and applications management software for critical business environments. Market cap: 0, Sector: Technology.
Last analyzed: Mar 17, 2026Integrated Research Limited (IREHF) Technology Profile & Competitive Position
Integrated Research Limited (IREHF) is a technology company focused on providing advanced systems and applications management software, particularly for unified communications and payment networks, with a strong presence in over 60 countries.
Investment Thesis
Integrated Research Limited presents a compelling investment thesis characterized by a market capitalization of $0.03 billion and a P/E ratio of 7.41, indicating potential undervaluation. The company's profit margin stands at 10.7%, supported by a robust gross margin of 76.4%, reflecting operational efficiency. Key growth catalysts include the increasing demand for unified communication solutions and the expansion of payment networks globally, which are projected to grow significantly over the next five years. Furthermore, Integrated Research's established presence in over 60 countries and its diverse customer base, including major banks and telecommunications companies, provide a solid foundation for future growth. However, investors may want to evaluate potential risks, including market competition and the company's reliance on specific sectors for revenue generation.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.03B indicates a small-cap status with growth potential.
- P/E ratio of 7.41 suggests potential undervaluation compared to industry peers.
- Profit margin of 10.7% reflects operational efficiency and cost management.
- Gross margin of 76.4% exceeds industry averages, showcasing strong product demand.
- Dividend yield of 6.67% provides attractive income potential for investors.
Competitors & Peers
Strengths
- Innovative software solutions tailored for critical business applications.
- Strong gross margins indicating operational efficiency.
- Established global presence with a diverse customer base.
- Experienced leadership team with a clear strategic vision.
Weaknesses
- Relatively small market capitalization may limit growth potential.
- Dependence on specific sectors could pose revenue risks.
- Limited brand recognition compared to larger competitors.
- Potential challenges in scaling operations in emerging markets.
Catalysts
- Upcoming: Launch of new features in the Prognosis software suite aimed at enhancing user experience and operational efficiency.
- Ongoing: Expansion into emerging markets in Asia-Pacific and Latin America, targeting new customer segments.
- Upcoming: Strategic partnerships with telecommunications companies to integrate unified communication solutions.
- Ongoing: Continued investment in R&D to innovate and enhance product offerings.
- Upcoming: Participation in industry conferences to showcase new technologies and attract potential clients.
Risks
- Potential: Increased competition from larger software firms could impact market share.
- Ongoing: Economic fluctuations may affect client budgets for software investments.
- Potential: Rapid technological advancements may necessitate continuous investment in R&D.
- Ongoing: Regulatory challenges in key markets could hinder operational expansion.
Growth Opportunities
- Growth opportunity 1: The global unified communications market is expected to grow from $69.9 billion in 2021 to $167.1 billion by 2026, representing a CAGR of 19.5%. Integrated Research's Prognosis software is well-positioned to capture this growth as organizations increasingly adopt unified communication solutions to enhance collaboration and efficiency.
- Growth opportunity 2: The payment processing software market is projected to grow significantly, driven by the rise of e-commerce and digital payment solutions. This market is expected to reach $30 billion by 2025, providing Integrated Research with opportunities to expand its offerings and integrate payment solutions into its existing software suite.
- Growth opportunity 3: The increasing demand for cloud-based solutions presents an opportunity for Integrated Research to enhance its SaaS offerings. As more businesses migrate to the cloud, the company can leverage its expertise to provide scalable and flexible software solutions tailored to client needs, potentially increasing revenue streams.
- Growth opportunity 4: The rise of artificial intelligence in software applications is transforming the industry. Integrated Research can capitalize on this trend by incorporating AI-driven analytics into its Prognosis suite, providing clients with enhanced insights and predictive capabilities, thereby increasing the product's value proposition.
- Growth opportunity 5: Expanding into emerging markets, particularly in Asia-Pacific and Latin America, can drive revenue growth for Integrated Research. These regions are experiencing rapid digital transformation, and the company's established reputation can facilitate entry and growth in these high-potential markets.
Opportunities
- Expanding market for unified communications and payment solutions.
- Growing demand for cloud-based software offerings.
- Potential for AI integration to enhance product capabilities.
- Emerging markets present new revenue opportunities.
Threats
- Intense competition from larger software companies.
- Rapid technological changes may outpace product development.
- Economic downturns could impact client spending on software.
- Regulatory changes in key markets may affect operations.
Competitive Advantages
- Strong brand reputation in the software application industry.
- Established relationships with key clients across various sectors.
- High gross margins indicating a competitive advantage in pricing power.
- Innovative product offerings that meet specific business-critical needs.
- Global presence allowing for diversified revenue streams and market resilience.
About IREHF
Integrated Research Limited, founded in 1988 and headquartered in North Sydney, Australia, is a leading provider of systems and applications management software tailored for business-critical computing environments. The company has evolved significantly since its inception, focusing on developing innovative solutions that enhance operational efficiency and insight for its clients. Its flagship product, Prognosis, is an integrated suite designed to monitor and manage various platforms, including HP NonStop systems and distributed servers, as well as unified communications and payment networks. This software suite is crucial for organizations needing real-time operational insights, particularly in sectors such as finance, telecommunications, and manufacturing. Integrated Research operates in approximately 60 countries, leveraging both direct sales and channel-driven distribution networks to reach its customers. The company serves a diverse clientele, including stock exchanges, banks, credit card companies, and service providers, positioning itself as a vital partner in ensuring the reliability and performance of critical business applications. With a workforce of 142 employees, Integrated Research continues to innovate and adapt to the ever-changing technological landscape, maintaining its competitive edge in the software application industry.
What They Do
- Design and develop systems management software for business-critical computing.
- Offer an integrated suite of monitoring and management software called Prognosis.
- Provide solutions for unified communications and payment networks.
- Deliver testing, maintenance, and professional services to clients.
- Offer software as a service (SaaS) solutions to enhance operational efficiency.
- Serve a diverse clientele, including banks, telecommunications, and service providers.
Business Model
- Generate revenue through software licensing and subscriptions for Prognosis.
- Provide professional services, including consulting and maintenance, to support clients.
- Leverage direct sales and channel partnerships to distribute products globally.
- Offer SaaS solutions to capture recurring revenue streams.
- Engage in international sales across approximately 60 countries to diversify income sources.
Industry Context
The software application industry is experiencing robust growth, driven by the increasing need for businesses to manage complex IT environments effectively. With the global software market projected to reach $1 trillion by 2025, companies like Integrated Research Limited are well-positioned to capitalize on this trend. The competitive landscape includes various players offering similar solutions; however, Integrated Research differentiates itself through its specialized focus on business-critical applications and unified communications. As enterprises continue to invest in digital transformation, the demand for Integrated Research's products is likely to increase, enhancing its market share.
Key Customers
- Stock exchanges requiring reliable systems for trading operations.
- Banks and financial institutions needing secure payment processing solutions.
- Telecommunications carriers looking for unified communication tools.
- Service providers aiming to enhance operational insights and efficiency.
- Manufacturers needing robust systems management for production environments.
Financials
Chart & Info
Integrated Research Limited (IREHF) stock price: Price data unavailable
Latest News
-
New 52-Week Lows For Monday Morning
· Aug 5, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IREHF.
Price Targets
Wall Street price target analysis for IREHF.
MoonshotScore
What does this score mean?
The MoonshotScore rates IREHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Ian Lowe
CEO
Ian Lowe has extensive experience in the technology sector, having held various leadership roles throughout his career. He has a strong background in software development and business management, which he leverages to drive Integrated Research's strategic initiatives. Ian holds a degree in Computer Science and has been instrumental in guiding the company through its growth phases.
Track Record: Under Ian's leadership, Integrated Research has expanded its product offerings and increased its global footprint, significantly enhancing its market position. His focus on innovation and customer satisfaction has led to improved operational efficiencies and revenue growth.
IREHF OTC Market Information
The OTC Other tier includes companies that do not meet the requirements for the higher tiers of OTC markets, such as OTCQX or OTCQB. This tier may have less stringent reporting standards, which can lead to less transparency for investors compared to stocks listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity can lead to price volatility and difficulty in executing trades.
- Less stringent reporting requirements may result in less transparency.
- Potential for higher volatility due to lower trading volumes.
- Company may face challenges in gaining wider investor recognition.
- Review financial statements for accuracy and completeness.
- Assess the company's competitive position and market trends.
- Evaluate management's track record and strategic vision.
- Consider the company's growth potential and market opportunities.
- Monitor industry developments and regulatory changes affecting the business.
- Established company with over 30 years in the software industry.
- Diverse customer base across multiple sectors enhances credibility.
- Regular financial reporting demonstrates transparency and accountability.
IREHF Technology Stock FAQ
What does Integrated Research Limited do?
Integrated Research Limited specializes in designing and developing systems management software for business-critical computing environments. Its flagship product, Prognosis, provides monitoring and management solutions for various platforms, including unified communications and payment networks, serving clients across multiple sectors globally.
What do analysts say about IREHF stock?
Analysts generally view IREHF as a company with potential for growth, given its strong gross margins and established market presence. Key valuation metrics suggest it may be undervalued compared to peers, with analysts focusing on its growth prospects in unified communications and payment solutions.
What are the main risks for IREHF?
Key risks for Integrated Research Limited include intense competition from larger software companies, potential economic downturns affecting client spending, and the need for continuous innovation to keep pace with technological advancements. Additionally, regulatory changes in key markets may pose operational challenges.
What are the key factors to evaluate for IREHF?
Integrated Research Limited (IREHF) currently holds an AI score of 47/100, indicating low score. Key strength: Innovative software solutions tailored for critical business applications.. Primary risk to monitor: Potential: Increased competition from larger software firms could impact market share.. This is not financial advice.
How frequently does IREHF data refresh on this page?
IREHF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven IREHF's recent stock price performance?
Recent price movement in Integrated Research Limited (IREHF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative software solutions tailored for critical business applications.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider IREHF overvalued or undervalued right now?
Determining whether Integrated Research Limited (IREHF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying IREHF?
Before investing in Integrated Research Limited (IREHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the latest available information and may be subject to updates. Investors should conduct their own research and due diligence.